Literature DB >> 8906799

Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin.

T Okura1, L Gong, T Kamitani, T Wada, I Okura, C F Wei, H M Chang, E T Yeh.   

Abstract

Fas/APO-1 and TNF receptor 1 share a common signaling motif in their cytoplasmic tail called the "death domain." Using the death domain as bait in the yeast two-hybrid system, several death domain-containing proteins that participate in cell death signaling have been identified. Here we report the isolation of a novel protein, sentrin, which interacts with Fas/APO-1 and TNF receptor 1 but not with FADD/MORT1 or CD40. Two-hybrid interaction assays reveal that sentrin associates only with the signal-competent forms of Fas/APO-1 or TNF receptor 1 death domains. Sentrin is a novel protein of 101 amino acids with homology to ubiquitin, Nedd8, and a Saccharomyces cerevisiae protein, Smt3. When overexpressed, sentrin provides protection against both anti-Fas/APO-1 and TNF-induced cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906799

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2.

Authors:  Y C Liu; J Pan; C Zhang; W Fan; M Collinge; J R Bender; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 2.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Tumor strengths and frailties: Cancer SUMmOns Otto's metabolism.

Authors:  Michael Ohh
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

4.  Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; C N Ellwood; N D Hall; D M Sansom
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

5.  Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

6.  A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.

Authors:  Germán Rosas-Acosta; William K Russell; Adeline Deyrieux; David H Russell; Van G Wilson
Journal:  Mol Cell Proteomics       Date:  2004-11-30       Impact factor: 5.911

7.  NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.

Authors:  Kunikazu Tanji; Tomoaki Tanaka; Fumiaki Mori; Katsumi Kito; Hitoshi Takahashi; Koichi Wakabayashi; Tetsu Kamitani
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Evolution of a signalling system that incorporates both redundancy and diversity: Arabidopsis SUMOylation.

Authors:  Renee Chosed; Sohini Mukherjee; Luisa Maria Lois; Kim Orth
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 9.  Role of desumoylation in the development of prostate cancer.

Authors:  Jinke Cheng; Tasneem Bawa; Peng Lee; Limin Gong; Edward T H Yeh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

10.  The SCF(COI1) ubiquitin-ligase complexes are required for jasmonate response in Arabidopsis.

Authors:  Linghui Xu; Fuquan Liu; Esther Lechner; Pascal Genschik; William L Crosby; Hong Ma; Wen Peng; Dafang Huang; Daoxin Xie
Journal:  Plant Cell       Date:  2002-08       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.